Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Systematic review: cardiovascular risk and mortality with rosiglitazone

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Wallach JD, et al. Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses. British Medical Journal 368: 5 Feb 2020. Available from: URL: https://doi.org/10.1136/bmj.l7078

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Systematic review: cardiovascular risk and mortality with rosiglitazone. Reactions Weekly 1791, 13 (2020). https://doi.org/10.1007/s40278-020-74858-5

    Download citation